In direct ELISAs, approximately 35% cross-reactivity with recombinant mouse IL-1 RAPL2/IL-1 R9 is observed. In Western blots, approximately 5% cross-reactivity with recombinant human (rh) IL-1 R7 is observed and less than 1% cross-reactivity with rhIL-1